EBS is a small biotechnology company whose forte is the clean processing and manufacturing facility that the FDA requires for certain bioprocessing to be certified for delivery of products to end-user patients. It is not a research facility like the one in China that accidentally released COVID and the global impact will be likely felt for another decade. ...
Added some levels for EBS after 20% up side EBS got news on approval on nasal product
1/1 line is a major Trend line Using the Fib circles the H&S pattern becomes more evident with the LS being rejected at the 1 level The H being formed at 1.618 and the RS being formed in the aftermath of the H formation I expect more downsides on this weekly timeframe until the strong support level is reached, which coincides also with the 1/2 Gann level
EBS looks like a solid buy, I am investing at current price, if it goes down then I will add around second support. Reasons to buy: RSI looks oversold Stock trading at long term trendline 2021 consensus earning estimate 9.01 which means 7~ PE. Volume is increasing which shows it is getting attention Once the FDA will approve its facility, it will fly....
bullish buy at 98.21, conserv buy at 94.61; 102.23 target, stop loss 89.64; r/r 1.93
Emergent BioSolutions is trying to break $71.19. RSI is below the trend and volume is not enough yet to get over
Rebounded from its bottom several days ago, the stock price is currently traded above its bearish channel’s resistance. We could assume the trend is reversing and the stock price would start to rise again after it retouch its new support at around $45.84.
I made this chart cus a friend asked me too. Eboost is bullish on the Ichimoku cloud. Eboost is also bouncing off the 50MA that also alines good with the bearish wedge at support. Yes the vedge is valled a bearish wedge so we need to be aware of short term downbreak. Other then that we can also see that the chart may be forming a cup&handle pattern, where only 3/4...
EBS left a Fast Ball XRV breakdown on Tuesday. The stock broke support and has as much as $1 of potential downside.